Entries by Rebecca.Mercer@cancercare.on.ca

PhD Opportunity: The use of Health Technology Assessment in publicly funded health systems

The Faculty of Health at Dalhousie University is inviting applications to consider entry into Dalhousie’s PhD Health program. This is an exciting opportunity to work with Dr. W. Dominika Wranik in the area of Health Technology Assessment, with particular focus on the application of HTA to policy questions in publicly (more…)

Funding Fair and Sustainable Cancer Programs and Services in British Columbia: A Deliberative Public Engagement

  Funding Fair and Sustainable Cancer Programs and Services in British Columbia: A Deliberative Public Engagement In Canada, provincial governments are responsible for funding health care.  When it comes to cancer, they are responsible for supporting patients and families through the full range of cancer programs and services, including prevention, (more…)

FDA’s RWE Framework

Earlier in December the FDA released a new framework outlining how they will use Real World Evidence (RWE) and Real World Data (RWD) in decision making for new drugs and biologics.  Under the new framework, the FDA will use the following three criteria to evaluate RWE/RWD: 1. Whether the RWD are fit (more…)

ARCC 2019 Abstract Submission NOW OPEN!

We are pleased to announce that abstract submission for the 2018 ARCC Conference is NOW OPEN! We encourage you to submit your work and join us in Halifax, May 27-28, 2019. Registration will open in mid-January 2019. Visit our conference webpage at  https://cc-arcc.ca/arcc-conference-2019/ for the most up-to-date conference information including (more…)